PI

Providence Investment Company Limited

North America, Georgia, United States, Germany

Description

Providence Investment Company

Investor Profile

Providence Investment Company Limited has backed more than 15 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biotechnology, Medical, Therapeutics.

Stage Focus

  • Series Unknown (47%)
  • Series B (20%)
  • Series A (13%)
  • Seed (13%)
  • Series C (7%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
  • Biopharma
  • Health Care
  • Pharmaceutical
  • Life Science
  • Genetics
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Providence Investment Company Limited frequently co-invest with?

Cambridge Consultants
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 3
AB
Europe, Cambridgeshire, United Kingdom, Madingley
Co-Investments: 3
Molten Ventures
Europe, England, United Kingdom, London
Co-Investments: 5
UK Innovation & Science Seed Fund
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 3
Cambridge Capital Group
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 4
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 2
Future Planet Capital
Europe, England, United Kingdom, London
Co-Investments: 3
Morningside Venture Partners
North America, New York, United States, New York
Co-Investments: 3
DCVC
North America, California, United States, San Francisco
Co-Investments: 3

Which angels does Providence Investment Company Limited often collaborate with?

David Evans
Oceania, New South Wales, Australia, Sydney
Shared Deals: 2
DC
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 1
PC
Europe, England, United Kingdom, London
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 3

What are some of recent deals done by Providence Investment Company Limited?

Cambridge Photon Technology

Cambridge, Cambridgeshire, United Kingdom

Cambridge Photon Technology is a developer of organic photovoltaic devices used to enhance next-generation solar technology.

EnergyEnergy ManagementSolar
Series UnknownNov 6, 2025
Amount Raised: $1,209,569
evonetix

Little Chesterford, Essex, United Kingdom

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

BiopharmaBiotechnologyLife Science
Series BFeb 7, 2023
Amount Raised: $24,108,294
evonetix

Little Chesterford, Essex, United Kingdom

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

BiopharmaBiotechnologyLife Science
Series BMar 2, 2020
Amount Raised: $30,000,000
evonetix

Little Chesterford, Essex, United Kingdom

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

BiopharmaBiotechnologyLife Science
Series AJan 30, 2018
Amount Raised: $12,300,000
DefiniGEN

Cambridge, Cambridgeshire, United Kingdom

Generating pre-clinical human data for therapeutic candidates with in-vitro liver and metabolic disease models.

BiotechnologyHealth CarePharmaceutical
Series BMay 23, 2016
Amount Raised: $2,172,282
CellCentric

Cambridge, Cambridgeshire, United Kingdom

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

BiotechnologyMedicalTherapeutics
Series UnknownOct 19, 2015
CellCentric

Cambridge, Cambridgeshire, United Kingdom

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

BiotechnologyMedicalTherapeutics
Series UnknownJun 25, 2013
Amount Raised: $6,631,852
Horizon Discovery

Cambridge, Cambridgeshire, United Kingdom

Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.

BiopharmaBiotechnologyGeneticsHealth Diagnostics
Series UnknownJun 3, 2013
Amount Raised: $10,559,533
Horizon Discovery

Cambridge, Cambridgeshire, United Kingdom

Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.

BiopharmaBiotechnologyGeneticsHealth Diagnostics
Series CSep 13, 2011
Amount Raised: $17,853,644
Phico Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series UnknownJan 1, 2009
Amount Raised: $1,458,423

Find More Investors Like Providence Investment Company Limited

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Providence Investment Company Limited | Pipeseed